Quantcast
Last updated on April 18, 2014 at 9:36 EDT

Latest Hepatitis C virus Stories

2013-10-01 12:30:34

RIDGEFIELD, Conn., Oct. 1, 2013 /PRNewswire/ -- New data from Boehringer Ingelheim's hepatitis C virus (HCV) clinical development program have been accepted for presentation at the 64(th) Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), also known as The Liver Meeting(®), taking place November 1-5 in Washington, D.C. Presentations will include data from several studies evaluating Boehringer Ingelheim's investigational compound, faldaprevir,...

2013-10-01 12:29:43

PHASE III TOP-LINE RESULTS EXPECTED BEGINNING LATER IN 2013 NORTH CHICAGO, Ill., Oct. 1, 2013 /PRNewswire/ -- AbbVie (NYSE: ABBV) announced that new data from its phase II hepatitis C clinical development program will be presented at The Liver Meeting, the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) in Washington, D.C., November 1-5, 2013. In total, eight abstracts will be presented, four of which include additional analyses from the phase IIb AVIATOR...

2013-10-01 08:31:32

CORK, Ireland, Oct. 1, 2013 /PRNewswire/ -- Janssen R&D Ireland (Janssen) announced that data will be presented on the investigational protease inhibitor simeprevir (TMC435) for the treatment of genotype 1 chronic hepatitis C in adult patients with compensated liver disease at the upcoming Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), which will take place November 1 to 5 in Washington, D.C. "Simeprevir's clinical profile has been characterized...

2013-09-10 08:28:46

First Phase 2a study includes Presidio's PPI-668 in genotype-1a infected patients; collaboration offers the potential to explore additional HCV genotypes in future trials RIDGEFIELD, Conn., Sept. 10, 2013 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced the completion of patient enrollment for a Phase 2a clinical trial (NCT01859962) investigating a new interferon-free, all-oral, direct-acting antiviral (DAA) combination treatment for patients with...

2013-09-09 12:27:43

However, Patient Awareness of Products in Development is Low, According to a New Report from BioTrends Research Group EXTON, Pa., Sept. 9, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds in their PatientTrends(®): Hepatitis C Virus (US) 2013 report that approximately 40 percent of surveyed treatment-naive hepatitis C virus (HCV) patients and half of the prior treatment...

2013-08-06 08:35:53

A Recent Audit of Patient Records Finds That Physicians are Foregoing Treatment of Their HCV Patients Until New Agents Become Available, According to a New Report from BioTrends Research Group EXTON, Pa., Aug. 6, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds that three-quarters of patients who have failed prior regimens, regardless of genotype, are not likely to re-treat their...

2013-08-05 23:17:34

System Represents Major Advance in Studying Virus New York, NY (PRWEB) August 05, 2013 By differentiating monkey stem cells into liver cells and inducing successful infection, researchers from the Icahn School of Medicine at Mount Sinai have shown for the first time that the hepatitis C virus (HCV) can replicate in monkeys, according to research published in the journal Gastroenterology. The new findings may lead to the first new animal model and provide new avenues for developing...

2013-08-05 08:01:27

System represents major advance in studying virus By differentiating monkey stem cells into liver cells and inducing successful infection, researchers from the Icahn School of Medicine at Mount Sinai have shown for the first time that the hepatitis C virus (HCV) can replicate in monkeys, according to research published in the journal Gastroenterology. The new findings may lead to the first new animal model and provide new avenues for developing treatments and vaccines for this disease,...

2013-07-24 16:24:45

NEW YORK, July 24, 2013 /PRNewswire/ -- On Thursday, July 25, 2013, the National Black Leadership Commission on AIDS, Inc. (NBLCA), in partnership with the Coalition for Positive Health Empowerment (COPE) and the Harm Reduction Coalition, is spearheading the first annual African American Hepatitis C Action Day, a national community mobilization initiative aimed at reducing the high incidence of HCV infection in black communities by drawing attention to this neglected health disparity...

2013-07-22 12:24:26

ReportsnReports.com adds new market research reports on United States for industries like wine, mattress, hepatitis C virus and more DALLAS, July 22, 2013 /PRNewswire-iReach/ -- With productivity and average hourly earnings increasing gradually, the United States economy seem to be fighting back, slowly but stably, out of recessionary times. ReportsnReports.com, in collaboration with is publishing partners, offers market research reports on United States for industries ranging from...


Latest Hepatitis C virus Reference Libraries

11_c18ff18c314281da28f1d18fa4357602
2011-01-20 19:28:48

Hepatitis E virus is an infective organism. The viral particles are 27 to 34 nanometers in diameter. They are non-enveloped and contain a single-strand of positive-sense RNA which is approximately 7300 bases in length. The virus was first visualized in 1983 and molecularly cloned in 1990. Previously it was classified in the family Caliciviridae. Its genome more closely resembles the rubella virus and is now classified as the only member of the genus Hepevirus which has not yet been...

11_9e88d15808b8ecc3fcbbdfcf4ae75786
2011-01-20 19:23:30

Hepatitis C virus (HCV) is an enveloped, positive-sense single-stranded RNA virus of the family Flaviviridae. It consists of a core of genetic material surrounded by an icosahedra protective shell of protein. The genome consists of a single open reading frame that is 9600 nucleotide bases long. HCV replication takes several steps. It primarily replicates in the hepatocytes of the liver. It can also reproduce in peripheral blood mononuclear cells. There is a wide variety of genotypes and...

More Articles (2 articles) »